BFC Planning’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
BFC Planning's CYTK Position: Q3 2026 in Review
BFC Planning held its Cytokinetics (CYTK) position steady in Q3 2026 at 72 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2712.
BFC Planning first reported a position in CYTK in Q3 2024 and has held it in 9 quarters since. The position peaked at $6.13K in Q2 2026. 354 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- BFC Planning held 72 shares of Cytokinetics worth $4.75K as of Q3 2026.
- BFC Planning left its Cytokinetics share count unchanged in Q3 2026.
- Cytokinetics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2712 holding.
- BFC Planning first reported a position in Cytokinetics in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Cytokinetics position peaked at $6.13K in Q2 2026.
- 354 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.